Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bal PharmaBOM:524824 -0.68%64 Days Inventory is 277.02 as of Mar. 2026, which is 44% above its 10-year median of 192.59. GuruFocus rates BOM:524824 with a GF Score™ of 64/100 and a GF Value™ of ₹97.39 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 923 Drug Manufacturers companies, Bal Pharma ranks worse than 77.25% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Bal Pharma's Average Total Inventories for the
three
months ended in Mar. 2026 was ₹1,164 Mil. Bal Pharma's Cost of Goods Sold for the
three
months ended in Mar. 2026 was ₹383 Mil.
Hence, Bal Pharma's Days Inventory for the
three
months ended in Mar. 2026 was 277.02.
The historical rank and industry rank for Bal Pharma's Days Inventory or its related term are showing as below:
BOM:524824'
s Days Inventory Range Over the Past 10 Years
Min: 146.57 Med: 192.59 Max: 295.37
Current: 255.76
During the past 13 years, Bal Pharma's highest Days Inventory was 295.37. The lowest was 146.57. And the median was 192.59.
BOM:524824's Days Inventory is ranked worse than 77.25% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.87
vs BOM:524824: 255.76
Bal Pharma's Days Inventory
increased
from Mar. 2025 (213.79) to Mar. 2026 (277.02).
It might indicate that Bal Pharma's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bal Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bal Pharma's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.38.
Bal Pharma (BOM:524824) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bal Pharma's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bal Pharma's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bal Pharma Days Inventory Related Terms
Bal Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Bal Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bal Pharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bal Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bal Pharma (BOM:524824) has a Days Inventory of 277.02 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bal Pharma and its competitors. This is 44% above median its historical median of 192.59. Over the past decade, Bal Pharma's Days Inventory has ranged from 146.57 to 295.37. According to the industry distribution chart, Bal Pharma ranks #713 out of 923 companies in the Drug Manufacturers industry, placing it in the top 77.2%.
Is Bal Pharma's Days Inventory too high?
Bal Pharma's current Days Inventory of 277.02 is 44% above median its 10-year median of 192.59. Over the past 10 years, this metric has ranged from a low of 146.57 to a high of 295.37. The Drug Manufacturers industry median Days Inventory is 164.87. Bal Pharma's value of 277.02 is 68% above this industry median. Based on the distribution chart, Bal Pharma ranks #713 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Bal Pharma has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bal Pharma's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Bal Pharma ranks #713 out of 923 companies for Days Inventory. This places Bal Pharma in the lower half of its industry. The industry median Days Inventory is 164.87. Bal Pharma's value of 277.02 is 68% above this benchmark. Historically, Bal Pharma's own Days Inventory has ranged from 146.57 to 295.37 over the past decade. While the company's 10-year median is 192.59 vs. the industry median of 164.87, Bal Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.87, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bal Pharma's current Days Inventory of 277.02 is 68% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bal Pharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bal Pharma's current Days Inventory is 277.02, which is 44% above median its own 10-year median of 192.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bal Pharma stock overvalued right now?
Based on GuruFocus' analysis, Bal Pharma (BOM:524824) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹97.39, compared to a current price of ₹88.10 — trading 9.5% below its estimated fair value. The current Days Inventory is 277.02, which is 44% above median its 10-year median of 192.59 and 68% above the Drug Manufacturers industry median of 164.87. Bal Pharma's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bal Pharma (BOM:524824), the current Days Inventory is 277.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bal Pharma (BOM:524824) Overvalued in 2026?
Based on GuruFocus' analysis, Bal Pharma stock appears to be undervalued.
The current stock price of ₹88.10 is trading 9.5% below its estimated GF Value™ of ₹97.39.
GuruFocus considers Bal Pharma to be Modestly Undervalued.
Key valuation signals for BOM:524824:
Days Inventory: 277.02 (44% above median its 10-year median of 192.59)
GF Value™: ₹97.39 vs. price of ₹88.10 (9.5% below fair value)
Industry Position: 68% above the Drug Manufacturers median (#713 of 923)
No single metric tells the full story. See the BOM:524824 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.
64GF Score
Get the complete analysis for BOM:524824
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524824 has been successfully added to your 
